CATALYST PHARMACEUTICALS, INC. Contracts & Agreements

93 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
EX-10.1 Employment Agreement with Patrick McEnany
Employment Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
FL
2006
Offer Letter between the Company and Richard J. Daly
CATALYST PHARMACEUTICALS, INC.
2024
Offer Letter between the Company and Michael W. Kalb
CATALYST PHARMACEUTICALS, INC.
2024
Separation Agreement between the Company and Patrick J. McEnany
Separation Agreements
CATALYST PHARMACEUTICALS, INC.
2024
Separation Agreement between the Company and Alicia Grande
Separation Agreements
CATALYST PHARMACEUTICALS, INC.
2024
Severance and Change in Control Plan
Change of Control Agreements
CATALYST PHARMACEUTICALS, INC.
2024
Underwriting Agreement dated January 4, 2024, between Catalyst Pharmaceuticals, Inc. and BofA Securities, Inc. and Citigroup Global Markets, Inc., as representatives of the...
Underwriting Agreements
CATALYST PHARMACEUTICALS, INC.
2024
Amendment to Transition Services Agreement between Eisai Inc., a subsidiary of Eisai and the Company, dated as of July 31, 2023 (certain identified information has been excluded...
Transition Agreements
CATALYST PHARMACEUTICALS, INC.
2023
Amendment to the Investment Agreement, dated as of July 18, 2023, between Santhera and the Company
Investment Agreements
CATALYST PHARMACEUTICALS, INC.
2023
License and Collaboration Agreement, executed and delivered as of June 19, 2023, by and between Santhera, its wholly-owned subsidiary, Santhera Pharmaceuticals (Schweiz) AG, and...
Collaboration Agreements
CATALYST PHARMACEUTICALS, INC.
2023
Investment Agreement, dated as of June 19, 2023, by and between Santhera and the Company (certain identified information has been excluded from the exhibit because it both (i) is...
Investment Agreements
CATALYST PHARMACEUTICALS, INC.
2023
Asset Purchase Agreement by and between Eisai and the Company, dated as of December 17, 2022 (certain identified information has been excluded from the exhibit because it both (i)...
Purchase Agreements
CATALYST PHARMACEUTICALS, INC.
2022
Form of Transition Services Agreement between Eisai, Inc., a subsidiary of Eisai, and the Company (certain identified information has been excluded from the exhibit because it...
Transition Agreements
CATALYST PHARMACEUTICALS, INC.
2022
Form of Supply Agreement between Eisai and the Company (certain identified information has been excluded from the exhibit because it both (i) is not material and (ii) would be...
Supply Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
DE
2022
Amendment No. 8 to Employment Agreement between the Company and Patrick J. McEnany, dated September 8, 2022
Employment Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
2022
Settlement Agreement, dated July 11, 2022, by and between the Company and SERB SA, on the one hand, and Jacobus Pharmaceutical Company Inc., PantherRx Specialty LLC, and Panther...
Settlement Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
NJ
2022
License and Asset Purchase Agreement, dated as of July 11, 2022, by and between Jacobus Pharmaceutical Company, Inc. and the Company
Purchase Agreements
CATALYST PHARMACEUTICALS, INC.
2022
Description of the Companys Capital Stock
Stock Agreements
CATALYST PHARMACEUTICALS, INC.
2022
License & Supply Agreement, dated as of June 28, 2021, between DyDo Pharma, Inc. and the Company (Certain identified information has been excluded from the exhibit because it both...
License Agreements
CATALYST PHARMACEUTICALS, INC.
2021
Description of the Companys Capital Stock
Stock Agreements
CATALYST PHARMACEUTICALS, INC.
2021
Amendment No. 7 to Employment Agreement between the Company and Patrick J. McEnany, dated September 9, 2020
Employment Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
2020
License & Supply Agreement, dated as of August 14, 2020, between KYE Pharmaceuticals, Inc. and the Company (Certain identified information has been excluded from the exhibit...
License Agreements
CATALYST PHARMACEUTICALS, INC.
2020
Fifth Amendment to Lease Agreement, dated effective as of May 7, 2020, among the Company and PRII 355 Alhambra Circle, LLC (Certain identified information has been excluded from...
Lease Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
2020
Description of the Companys Capital Stock
Stock Agreements
CATALYST PHARMACEUTICALS, INC.
2020
Amendment No. 2 to Rights Agreement, dated as of August 28, 2019, between Catalyst Pharmaceuticals, Inc. and Continental Stock Transfer and Trust Company, as Rights Agent
CATALYST PHARMACEUTICALS, INC.
2019
Amendment No. 2 to License Agreement, made and entered into effective as of May 29, 2019, by and between BioMarin and the Company (certain identified information has been excluded...
License Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
2019
Amendment No. 1 to Collaborative Agreement with Endo for generic Sabril (certain identified information has been excluded from this exhibit because it is both (i) not material and...
CATALYST PHARMACEUTICALS, INC.
Biotechnology
2019
Development, License and Commercialization Agreement by and between the Company and Endo Ventures Limited, dated as of December 18, 2018 (portions of this exhibit have been...
License Agreements
CATALYST PHARMACEUTICALS, INC.
2018
Fourth Amendment to Lease, dated effective as of August 13, 2018, between the Company and PRII 355 Alhambra Circle, LLC (portions of this exhibit have been omitted and filed...
Lease Agreements
CATALYST PHARMACEUTICALS, INC.
2018
Settlement Agreement, effective as of July 26, 2018, among the Company, BioMarin Pharmaceutical Inc. and Aceras BioMedical LLC, in its capacity as stockholder representative for...
Settlement Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
NY
2018
Amendment No. 6 to Employment Agreement between the Company and Patrick J. McEnany, dated May 25, 2018
Employment Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
2018
Underwriting Agreement, dated November 28, 2017, between Catalyst Pharmaceuticals, Inc. and Piper Jaffray & Co., as representative of the underwriters named in Schedule I thereto
Underwriting Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
NY
2017
AMENDMENT NO. 1 TO RIGHTS AGREEMENT
CATALYST PHARMACEUTICALS, INC.
2016
FIFTH AMENDMENT TO EMPLOYMENT AGREEMENT
Employment Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
2016
CONFIDENTIAL TREATMENT REQUESTED Redacted portions are indicated by [****]1 THIRD AMENDMENT TO LEASE
Lease Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
2015
CONFIDENTIAL TREATMENT REQUESTED Redacted portions are indicated by [****]1 THIRD AMENDMENT TO LEASE
Lease Agreements
CATALYST PHARMACEUTICALS, INC.
2015
10,000,000 Shares Catalyst Pharmaceutical Partners, Inc. Common Stock UNDERWRITINGAGREEMENT
Stock Agreements
CATALYST PHARMACEUTICALS, INC.
2015
CONFIDENTIAL TREATMENT REQUESTED Redacted portions are indicated by [****]1 AMENDMENT NO. 1 TO LICENSE AGREEMENT
License Agreements
CATALYST PHARMACEUTICALS, INC.
2014
13,023,750 Shares CatalystPharmaceutical Partners, Inc. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
CATALYST PHARMACEUTICALS, INC.
2014
CATALYST PHARMACEUTICAL PARTNERS, INC. 2014 STOCK INCENTIVE PLAN
Bonus & Incentive Agreements
CATALYST PHARMACEUTICALS, INC.
2014
SECOND AMENDMENT TO LEASE
Lease Agreements
CATALYST PHARMACEUTICALS, INC.
2014
TERMINATION AGREEMENT
Termination Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
2013
[To be separately provided to the Investor]
CATALYST PHARMACEUTICALS, INC.
2013
CATALYST PHARMACEUTICAL PARTNERS, INC. 8,800,000 shares of Common Stock PLACEMENT AGENT AGREEMENT
Stock Agreements
CATALYST PHARMACEUTICALS, INC.
2013
FOURTH AMENDMENT TO EMPLOYMENT AGREEMENT
Employment Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
2013
CONFIDENTIAL TREATMENT REQUESTED Redacted portions are indicated by[****]1 LICENSE AGREEMENT
License Agreements
CATALYST PHARMACEUTICALS, INC.
2013
CONVERTIBLE PROMISSORY NOTE AND NOTE PURCHASE AGREEMENT
Note Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
CA
2012
CONFIDENTIAL TREATMENT REQUESTED Redactedportions are indicated by [****]1 LICENSE AGREEMENT
License Agreements
CATALYST PHARMACEUTICALS, INC.
2012
[To be separately provided to the Investor]
CATALYST PHARMACEUTICALS, INC.
Biotechnology
NY
2012
CATALYST PHARMACEUTICAL PARTNERS, INC. WARRANT TO PURCHASE COMMON STOCK
Warrant Agreements
CATALYST PHARMACEUTICALS, INC.
2012
CATALYST PHARMACEUTICAL PARTNERS, INC. 4,000,000 shares of Common Stock and Warrants to purchase up to 1,200,000 shares of Common Stock PLACEMENTAGENT AGREEMENT
Stock Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
CA
2012
6,000,000 Shares Warrants to Purchase 6,000,000 Shares Catalyst Pharmaceutical Partners, Inc. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
NY
2012
[ ] Shares Warrants to Purchase [ ] Shares Catalyst Pharmaceutical Partners, Inc. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
CATALYST PHARMACEUTICALS, INC.
2012
CATALYST PHARMACEUTICAL PARTNERS, INC. WARRANT TO PURCHASE COMMON STOCK
Warrant Agreements
CATALYST PHARMACEUTICALS, INC.
2012
[ ] Shares Catalyst Pharmaceutical Partners, Inc. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
NY
2012
LICENSE AGREEMENT
License Agreements
CATALYST PHARMACEUTICALS, INC.
2012
CATALYST PHARMACEUTICAL PARTNERS, INC. 3,046,740 shares of Common Stock and Warrants to purchase up to 1,523,370 shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
CA
2011
CATALYST PHARMACEUTICAL PARTNERS, INC. WARRANT TO PURCHASE COMMON STOCK
Warrant Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
NY
2011
RIGHTS AGREEMENT between CATALYST PHARMACEUTICAL PARTNERS, INC. and CONTINENTAL STOCK TRANSFER AND TRUST COMPANY as Rights Agent Dated as of September 20, 2011 TABLE OF CONTENTS
Registration Rights Agreements
CATALYST PHARMACEUTICALS, INC.
2011
THIRD AMENDMENT TO EMPLOYMENT AGREEMENT
Employment Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
2011
FIRST AMENDMENT TO LEASE
Lease Agreements
CATALYST PHARMACEUTICALS, INC.
2011
2,259,943 Shares CATALYST PHARMACEUTICAL PARTNERS, INC. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
CATALYST PHARMACEUTICALS, INC.
2011
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
CATALYST PHARMACEUTICALS, INC.
2010
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
CATALYST PHARMACEUTICALS, INC.
2010
SECOND AMENDMENT TO EMPLOYMENT AGREEMENT
Employment Agreements
CATALYST PHARMACEUTICALS, INC.
2009
Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC
CATALYST PHARMACEUTICALS, INC.
Biotechnology
NY
2009
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
NY
2009
LICENSE AGREEMENT
License Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
IL
2009
FIRST AMENDMENT TO EMPLOYMENT AGREEMENT
Employment Agreements
CATALYST PHARMACEUTICALS, INC.
2008
Catalyst Pharmaceutical Partners, Inc. 355 Alhambra Circle Suite 1370 Coral Gables, Florida 33134
CATALYST PHARMACEUTICALS, INC.
2008
Ex-10.1 Engagement Letter
CATALYST PHARMACEUTICALS, INC.
2008
Ex-10.2 Form of Securities Purchase Agreement
Purchase Agreements
CATALYST PHARMACEUTICALS, INC.
2008
EX-10.1 Consulting Agreement
Consulting Agreements
CATALYST PHARMACEUTICALS, INC.
2008
EX-10.1 Lease Agreement
Lease Agreements
CATALYST PHARMACEUTICALS, INC.
2007
AMENDMENT NO. 1 TO CONSULTING AGREEMENT
Consulting Agreements
CATALYST PHARMACEUTICALS, INC.
2007
EX-10.2 Employment Agreement with Jack Weinstein
Employment Agreements
CATALYST PHARMACEUTICALS, INC.
Biotechnology
FL
2006
EX-10.3 Stock Option Agreement
Stock Agreements
CATALYST PHARMACEUTICALS, INC.
2006
EX-1.1 Form of Underwriting Agreement
Underwriting Agreements
CATALYST PHARMACEUTICALS, INC.
2006
EX-4.1 Specimen Stock Certificate
Stock Agreements
CATALYST PHARMACEUTICALS, INC.
2006
EX-10.1 Form of Employment Agreement w/Patrick J. McEnany
Employment Agreements
CATALYST PHARMACEUTICALS, INC.
2006
EX-10.2 Form of Employment Agreement w/Jack Weinstein
Employment Agreements
CATALYST PHARMACEUTICALS, INC.
2006
EX-10.9 Agreement and Plan of Merger
Merger Agreements
CATALYST PHARMACEUTICALS, INC.
2006
EX-10.10 Consulting Agreement as amended/Weinstein
Consulting Agreements
CATALYST PHARMACEUTICALS, INC.
2006
EX-10.11 Consulting Agreement w/Charles O'keefe
Consulting Agreements
CATALYST PHARMACEUTICALS, INC.
2006
EX-10.12 Agreement with Donald Jasinski
CATALYST PHARMACEUTICALS, INC.
2006
EX-10.13 Agreement with Charles Gorodetzky
CATALYST PHARMACEUTICALS, INC.
2006
EX-10.14 Agreement with Pharmaceutics International Inc
CATALYST PHARMACEUTICALS, INC.
2006
EXHIBIT 10.3 LICENSE AGREEMENT
License Agreements
CATALYST PHARMACEUTICALS, INC.
2006
EXHIBIT 10.4 STOCK OPTION AGREEMENTS/PATRICK J. MCENANY
Stock Agreements
CATALYST PHARMACEUTICALS, INC.
2006
EXHIBIT 10.5 STOCK OPTION AGREEMENTS/HUBERT HUCKEL
Stock Agreements
CATALYST PHARMACEUTICALS, INC.
2006
EXHIBIT 10.6 STOCK OPTION AGREEMENTS/JACK WEINTSTEIN
Stock Agreements
CATALYST PHARMACEUTICALS, INC.
2006
EXHIBIT 10.7 STOCK OPTION AGREEMENTS/CHARLES O'KEEFE
Stock Agreements
CATALYST PHARMACEUTICALS, INC.
2006
EXHIBIT 10.8 STOCK INCENTIVE PLAN
Bonus & Incentive Agreements
CATALYST PHARMACEUTICALS, INC.
2006